Not applicableUnknownNCT03964922
What this trial is testing
Immunoevasive Tactics Employed by Myeloid Malignancy After Allogeneic Stem Cell Transplantation
Who this might be right for
Relapse LeukemiaAllogeneic Stem Cell TransplantationImmune Evasion, Tumor
Central Hospital, Nancy, France 104